Christopher G. White - 01 Oct 2021 Form 4 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Role
Chief Business Officer
Signature
/s/ Donald Notman, Attorney-in-Fact for Christopher G. White
Issuer symbol
OCUL
Transactions as of
01 Oct 2021
Net transactions value
$0
Form type
4
Filing time
08 Oct 2021, 16:34:07 UTC
Next filing
07 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUL Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 01 Oct 2021 Common Stock 20,000 $10.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.